Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 21, 2015; 21(11): 3274-3281
Published online Mar 21, 2015. doi: 10.3748/wjg.v21.i11.3274
Published online Mar 21, 2015. doi: 10.3748/wjg.v21.i11.3274
Table 3 Five-year recurrence-free survival stratified by lymph node ratio and pN-category according to the number of harvested lymph nodes
No PCRT | PCRT | |||||||
< 12 | P value | ≥12 | P value | < 12 | P value | ≥12 | P value | |
p/yp N1 | 67.8% | 0.01 | 79.2% | < 0.001 | 43.8% | 0.90 | 62.4% | 0.080 |
p/yp N2 | 43.3% | 55.0% | 36.5% | 47.2% | ||||
LNR1 | 74.2% | 0.01 | 76.6% | < 0.001 | 50.2% | 0.05 | 63.0% | 0.007 |
LNR2 | 51.3% | 53.6% | 31.9% | 38.1% |
- Citation: Park IJ, Yu CS, Lim SB, Yoon YS, Kim CW, Kim TW, Kim JH, Kim JC. Ratio of metastatic lymph nodes is more important for rectal cancer patients treated with preoperative chemoradiotherapy. World J Gastroenterol 2015; 21(11): 3274-3281
- URL: https://www.wjgnet.com/1007-9327/full/v21/i11/3274.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i11.3274